Association of PeRiODontal Disease and gUt Microbiome With Coronary artEry Disease (PRODUCE Study)
1 other identifier
observational
450
1 country
1
Brief Summary
The purpose of this study is to explore the relationship between periodontal disease and coronary artery disease through changes in the gut microbiome. In addition, the investigators aim to find possible periodontal pathogens that have association with cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2024
CompletedJanuary 1, 2025
December 1, 2024
2.4 years
September 19, 2022
December 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The association between periodontal disease and cardiovascular disease
The association between periodontal disease and cardiovascular disease by chi-square test The difference of relative abundance in gut microbiome by PERMANOVA test Safety Issue: No
within 3 years after enrollment (until the completion of dataset)
Secondary Outcomes (2)
The associations among periodontitis, gut microbiome and biomarkers
within 3 years after enrollment (until the completion of dataset)
The associations between periodontitis and cognitive function
within 3 years after enrollment (until the completion of dataset)
Study Arms (2)
Coronary artery disease
control
Eligibility Criteria
Patients aged from 19 to 80 years who underwent invasive coronary angiography for clinical necessity in single tertiary hospital
You may qualify if:
- Patients aged from 19 to 80 years who underwent invasive coronary angiography for clinical necessity, with informed consent
You may not qualify if:
- Patients with prosthetic valve
- pregnancy
- active malignancy
- active autoimmune disease
- active inflammatory bowel disease
- chronic kidney disease (eGFR\<30, or on dialysis)
- Active liver disease or liver cirrhosis
- consistent use of probiotics
- prior gastrointestinal surgery within 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yonsei University Health System, Severance Hospital
Seoul, South Korea
Biospecimen
Blood, Stool, and Gingival crevicular fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jong-Won Ha
Severance Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2022
First Posted
September 29, 2022
Study Start
July 1, 2022
Primary Completion
December 5, 2024
Study Completion
December 5, 2024
Last Updated
January 1, 2025
Record last verified: 2024-12